Döhner, H., Döhner, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., . . . Lichter, P. (1995). p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood, 85(6), . https://doi.org/10.1182/blood.V85.6.1580.bloodjournal8561580
Chicago-Zitierstil (17. Ausg.)Döhner, Hartmut, et al. "P53 Gene Deletion Predicts for Poor Survival and Non-response to Therapy with Purine Analogs in Chronic B-cell Leukemias." Blood 85, no. 6 (1995). https://doi.org/10.1182/blood.V85.6.1580.bloodjournal8561580.
MLA-Zitierstil (9. Ausg.)Döhner, Hartmut, et al. "P53 Gene Deletion Predicts for Poor Survival and Non-response to Therapy with Purine Analogs in Chronic B-cell Leukemias." Blood, vol. 85, no. 6, 1995, https://doi.org/10.1182/blood.V85.6.1580.bloodjournal8561580.